Fig. 6From: Oxygen-enhanced MRI assessment of tumour hypoxia in head and neck cancer is feasible and well tolerated in the clinical settingScatter plot showing categorisation of hypoxia status of primary tumours (a) and malignant nodes (b) based on VOI average median ΔT1 times and ΔR2* rates with error bars indicating estimates of 95% confidence intervals derived from Bootstrap sampling with 1,000 samples. Data points corresponding to primary tumours with evidence of residual disease post-radiotherapy treatment are shown with blue circles. VOI Volume of interestBack to article page